Ally Bridge Group (ABG) is a healthcare investment group that focuses on buyout, growth and venture investments in the US, Europe and China. It adopts a China-global cross-border strategy and targets industries such as life sciences, disruptive technology platforms in both medical devices and bio-pharmaceuticals. ABG is based in Hong Kong with offices in the US and China.
Growth
3 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.